Charles River Laboratories International Inc (CRL)
228.44
-10.99
(-4.59%)
USD |
NYSE |
Apr 25, 13:11
Charles River Laboratories International Cash from Financing (Quarterly): 123.57M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 123.57M |
| September 30, 2023 | -162.87M |
| June 30, 2023 | -71.46M |
| March 31, 2023 | 25.24M |
| December 31, 2022 | -248.96M |
| September 30, 2022 | -51.59M |
| June 30, 2022 | 271.44M |
| March 31, 2022 | -13.28M |
| December 31, 2021 | -218.97M |
| September 30, 2021 | 178.90M |
| June 30, 2021 | 517.96M |
| March 31, 2021 | 194.72M |
| December 31, 2020 | -59.23M |
| September 30, 2020 | -268.64M |
| June 30, 2020 | -104.10M |
| March 31, 2020 | 479.21M |
| December 31, 2019 | -39.04M |
| September 30, 2019 | -133.44M |
| June 30, 2019 | 473.51M |
| March 31, 2019 | -69.08M |
| December 31, 2018 | 0.563M |
| September 30, 2018 | -147.08M |
| June 30, 2018 | 719.51M |
| March 31, 2018 | -14.94M |
| December 31, 2017 | -53.01M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.402M |
| June 30, 2017 | -80.74M |
| March 31, 2017 | -74.32M |
| December 31, 2016 | -23.93M |
| September 30, 2016 | -105.57M |
| June 30, 2016 | 510.54M |
| March 31, 2016 | -0.294M |
| December 31, 2015 | 4.182M |
| September 30, 2015 | 52.29M |
| June 30, 2015 | -65.66M |
| March 31, 2015 | 1.934M |
| December 31, 2014 | 17.12M |
| September 30, 2014 | -33.92M |
| June 30, 2014 | 84.36M |
| March 31, 2014 | -6.144M |
| December 31, 2013 | -15.91M |
| September 30, 2013 | -38.91M |
| June 30, 2013 | -22.91M |
| March 31, 2013 | -6.51M |
| December 31, 2012 | -18.11M |
| September 30, 2012 | -27.54M |
| June 30, 2012 | -34.84M |
| March 31, 2012 | -30.64M |
| December 31, 2011 | -56.01M |
| September 30, 2011 | -106.14M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-268.64M
Minimum
Sep 2020
517.96M
Maximum
Jun 2021
47.00M
Average
-39.04M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Cardinal Health Inc | -353.00M |
| Stryker Corp | -286.00M |
| DaVita Inc | -403.25M |
| Inotiv Inc | -2.921M |
| Medpace Holdings Inc | 7.66M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 220.94M |
| Cash from Investing (Quarterly) | -238.37M |
| Free Cash Flow | 365.37M |
| Free Cash Flow Per Share (Quarterly) | 2.779 |
| Free Cash Flow to Equity (Quarterly) | 9.69M |
| Free Cash Flow to Firm (Quarterly) | 171.55M |
| Free Cash Flow Yield | 3.11% |